Instruction for use: Serpafar

Active substance Clomifene

ATX code G03GB02 Clomifene

Pharmacological group

Estrogens, gestagens; Their homologues and antagonists

Nosological classification (ICD-10)

N91 Lack of menstruation, meager and rare menstruation

Amenorrhea, Amenorrhea hypogonadotropic, Amenorrhea is prolactin-dependent, Oligomenorrhoea, Shortening of the secretory phase of the menstrual cycle, Menstrual disorders, Menstruation disorders, Prolactin-dependent amenorrhea without galactorrhea

N93 Other abnormal bleeding from the uterus and vagina

Atonic uterine bleeding, Prolonged menstruation, Blood loss during menstruation, Bleeding from the genitourinary system, Bleeding uterine dysfunctional, Bleeding from the genital tract of organic etiology, Uterine bleeding, Menorrhagia with fibroids, Functional uterine bleeding, Abnormal bleeding from the genitals in women

N97 Female infertility

Female infertility in anovulation, Hyperprolactinemic infertility, Hyperprolactinaemia with infertility, Endocrine infertility, Infertility due to hypothalamic-pituitary dysfunction, Infertility infertility, Infertility, Infertility on the background of hyperprolactinaemia, Functional infertility, Marriage is infertile, Infertility of ovarian genesis, Stimulation of the growth of a single follicle

Composition and form of release

1 tablet contains clomifene citrate 50 mg, in a package of 20 pcs.

pharmachologic effect

The pharmacological action is antiestrogenic.

indications

Anovulatory infertility, dysfunctional metrorrhagia, disgonadotropic amenorrhea.

Contraindications

Endometrial, breast, thromboembolic disease, hepatic insufficiency, jaundice, epilepsy, metrorrhagia of unclear etiology, pregnancy.

Side effects

Dizziness, headache, depression, irritability, insomnia, nausea, vomiting, bloating, weight gain, pain in the abdomen, vasomotor symptoms, hot flushes, transient visual disturbances, hyperplasia of the ovary, hair loss, rash, mastalgia, dysmenorrhoea, increased frequency of urination, Polyuria.

Dosing and Administration

Inside, administered to stimulate ovulation 50 mg 1 time a day at bedtime, starting from 5th day of the menstrual cycle during 5 days. In the absence of effect, the daily dose is increased to 200 mg, prolonging the course to 10 days.

storage conditions

In the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.